Additive Manufactured Intelligent Patches For Wound Management

Skin disease proves an issue of urgency, as they are the fourth most common cause of human disease, impacting nearly one-third of the global population. Due to the cost and complexity of topical products ranging from creams to assisted technology, an alternative solution for wound healing and skin lesion treatment is desired. Additive manufacturing has been used for various applications in healthcare including personalized prosthetics, implants, and models for surgical education. According to literature, the use of 3D printing as a means of development for personalized topical dosage forms and wound dressings reveals promising as it allows for use of materials with various physical and mechanical properties. Although this is the case, current 3D printed applications for wound healing dressings are generic regarding their dosage forms, and require personalization to provide individuals with an appropriate quantity in accordance with weight, genetics, age, and health conditions. The primary objective of this study is to resolve generic drug delivery systems through proving the broad applicability of 3D printing in the production of wound healing dressings. In this study, the active drug delivery of neomycin will be tested through three dressings of parallel, crosshatched, and 45 degree crosshatched patterns. The wound healing dressings will be tested through the use of thermally responsive and pH responsive polymers in an in vitro study to assess effectivity of the dressing under conditions similar to that of an inflamed wound site. The durability of the wound healing dressing will also be tested through the evaluation of the degradation of hydrogel through incubation and dialysis bag techniques

Additive Manufactured Intelligent Patches For Wound Management

Skin disease proves an issue of urgency, as they are the fourth most common cause of human disease, impacting nearly one-third of the global population. Due to the cost and complexity of topical products ranging from creams to assisted technology, an alternative solution for wound healing and skin lesion treatment is desired. Additive manufacturing has been used for various applications in healthcare including personalized prosthetics, implants, and models for surgical education. According to literature, the use of 3D printing as a means of development for personalized topical dosage forms and wound dressings reveals promising as it allows for use of materials with various physical and mechanical properties. Although this is the case, current 3D printed applications for wound healing dressings are generic regarding their dosage forms, and require personalization to provide individuals with an appropriate quantity in accordance with weight, genetics, age, and health conditions. The primary objective of this study is to resolve generic drug delivery systems through proving the broad applicability of 3D printing in the production of wound healing dressings. In this study, the active drug delivery of neomycin will be tested through three dressings of parallel, crosshatched, and 45 degree crosshatched patterns. The wound healing dressings will be tested through the use of thermally responsive and pH responsive polymers in an in vitro study to assess effectivity of the dressing under conditions similar to that of an inflamed wound site. The durability of the wound healing dressing will also be tested through the evaluation of the degradation of hydrogel through incubation and dialysis bag techniques

Fifty Shades of Black: Analysis of Thin Film of Electro-sprayed Anti-radiation Coating of Melanin Nanoparticles

Melanin, an organic dark pigment naturally produced in the skin tissues of most mammals, is known to shield cells from radiation damage by absorbing ultraviolet radiation. The IGNITE project’s objective is to fabricate synthetic melanin nanoparticles that simulate natural radiation-blocking material. Overall, the project is three-parted: firstly, a melanin nanoparticles solution will be synthesized using chitosan and polyethylene glycol solutions; secondly, the nanoparticles will be electro-sprayed onto glass slides in order to produce a wide range of thin films with varying degrees of film thickness; finally, radiation blocking tests will be conducted to evaluate the thickness range in which the films are able to absorb radiation. Within the aerospace and manufacturing industries, these thin films of melanin nanoparticles could satisfy the need for a novel organic radiation-blocking material in order to better protect workers. Specific applications are the coating of high-altitude aircraft and spacecraft’s external surfaces, as well as spacesuits and helmets. Furthermore, it may provide a valid organic and allergen-free replacement for the inorganic compounds found in most commercial sunscreens

The murine catecholamine methyltransferase mTOMT is essential for mechanotransduction by cochlear hair cells

Hair cells of the cochlea are mechanosensors for the perception of sound. Mutations in the LRTOMT gene, which encodes a protein with homology to the catecholamine methyltransferase COMT that is linked to schizophrenia, cause deafness. Here, we show that Tomt/Comt2, the murine ortholog of LRTOMT, has an unexpected function in the regulation of mechanotransduction by hair cells. The role of mTOMT in hair cells is independent of mTOMT methyltransferase function and mCOMT cannot substitute for mTOMT function. Instead, mTOMT binds to putative components of the mechanotransduction channel in hair cells and is essential for the transport of some of these components into the mechanically sensitive stereocilia of hair cells. Our studies thus suggest functional diversification between mCOMT and mTOMT, where mTOMT is critical for the assembly of the mechanotransduction machinery of hair cells. Defects in this process are likely mechanistically linked to deafness caused by mutations in LRTOMT/Tomt

Anti-Saccade Performance Predicts Executive Function and Brain Structure in Normal Elders

Objective—To assess the neuropsychological and anatomical correlates of anti-saccade (AS) task performance in normal elders. Background—The AS task correlates with neuropsychological measures of executive function and frontal lobe volume in neurological diseases, but has not been studied in a well-characterized normal elderly population. Because executive dysfunction can indicate an increased risk for cognitive decline in cognitively normal elders, we hypothesized that AS performance might be a sensitive test of age-related processes that impair cognition. Method—The percentage of correct AS responses was evaluated in forty-eight normal elderly subjects and compared with neuropsychological test performance using linear regression analysis and gray matter volume measured on MRI scans using voxel-based morphometry. Results—The percentage of correct AS responses was associated with measures of executive function, including modified trails, design fluency, Stroop inhibition, abstraction, and backward digit span, and correlated with gray matter volume in two brain regions involved in inhibitory control: the left inferior frontal junction and the right supplementary eye field. The association of AS correct responses with neuropsychological measures of executive function was strongest in individuals with fewer years of education. Conclusions—The AS task is sensitive to executive dysfunction and frontal lobe structural alterations in normal elders

Fever of Unknown Origin with Final Diagnosis of Imported Malaria: A Case Study

One of the most important infectious diseases in the world is Malaria. About half of the world populations are exposed to the risk of the disease. The program for controlling and eradication of Malaria has been being conducted in our country since many years ago. One of the public health problems in the endemic and non-endemic countries is Imported Malaria which can cause new and permanent infected foci. Population movement and travelling from endemic areas can transmit the disease to the clean areas and can also transmit the drug resistant Protozoa particularly Plasmodium Falciparum. Our case study describes a 30 year old person who has travelled to India for one month. He has visited a doctor in India because of fever, chills, malaise, and has received symptomatic treatment without any specific diagnosis .After returning to Iran, the symptoms appeared again after visiting by a doctor he has hospitalized with a diagnosis of Fever of unknown origin (FUO).He was checked for three days and on the fourth day, the blood smear of the patient showed Plasmodium Vivax. Ultimately he received the appropriate treatment and was discharged from the hospital in a good condition

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019

An updated exploration of the burden of thyroid cancer across a country is always required for making correct decisions. The objective of this study is to present the thyroid cancer burden and attributed burden to the high Body Mass Index (BMI) in Iran at national and sub-national levels from 1990 to 2019. The data was obtained from the GBD 2019 study estimates. To explain the pattern of changes in incidence from 1990 to 2019, decomposition analysis was conducted. Besides, the attribution of high BMI in the thyroid cancer DALYs and deaths were obtained. The age-standardized incidence rate of thyroid cancer was 1.57 (95% UI: 1.33–1.86) in 1990 and increased 131% (53–191) until 2019. The age-standardized prevalence rate of thyroid cancer was 30.19 (18.75–34.55) in 2019 which increased 164% (77–246) from 11.44 (9.38–13.85) in 1990. In 2019, the death rate, and Disability-adjusted life years of thyroid cancer was 0.49 (0.36–0.53), and 13.16 (8.93–14.62), respectively. These numbers also increased since 1990. The DALYs and deaths attributable to high BMI was 1.91 (0.95–3.11) and 0.07 (0.04–0.11), respectively. The thyroid cancer burden and high BMI attributed burden has increased from 1990 to 2019 in Iran. This study and similar studies’ results can be used for accurate resource allocation for efficient management and all potential risks’ modification for thyroid cancer with a cost-conscious view